Материалов:
1 081 645

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 1081645

Страница 1 из 108165

Clinical and pharmacological aspects of drug-induced long-qt syndrome
Balykova L. A.
Feasibility of targeted antiviral therapy for acute respiratory viral infections in the COVID-19 pandemic
Omarova K.G., Balykova L.A., Pshenichnaya N.Yu., Zemskov D.N., Zaslavskaya K.Ya., Taganov A.V., Belyy P.A.
Myocarditis in children. Etiology. Pathogenesis. Epidemiology. Clinical presentation; [Миокардиты у детей. Этиология. Патогенез. Эпидемиология. Клиничеcкая картина]
Vasichkina E.S., Balykova L.A., Basargina E.N., Bregel L.V., Degtyareva E.A., Kovalev I.A., Kotlukova N.P., Leontieva I.V., Yakovleva L.V., Groznova O.S., Vladimirov D.O.
CONCLUSION OF EXPERTS. NEW POSSIBILITIES OF ETIOTROPIC THERAPY OF CORONAVIRUS INFECTION
Chulanov V.P., Pushkar D.Yu., Balykova L.A., Gorelov A.V., Lioznov D.A., Dmitriev A.S., Kolontarev K.B., Malyavin A.G., Budnevsky A.V., Esaulenko E.V., Petrov V.A., Taganov A.V., Pshenichnaya N.Yu., Omarova K.G.
Efficacy and safety of some etiotropic therapeutic schemes for treating patients with novel coronavirus infection (covid-19)
Balykova L. A.
Characteristics of covid-19 and possibilities of early causal therapy. Results of favipiravir use in clinical practice
Balykova L. A.
Features of cytokine status dynamics in patients with COVID-19 using Ambervin® Pulmo; [Особенности динамики цитокинового статуса пациентов с COVID-19 на фоне применения препарата Амбервин® Пульмо]
Radaeva O.A., Balykova L.A., Pyataev N.A., Zaslavskaya K.Ya., Kostina Y.A., Eremeev V.V., Taganov A.V., Belyy P.A.
EFFECTIVENESS AND SAFETY OF FAVIPIRAVIR INFUSION IN PATIENTS HOSPITALIZED WITH COVID-19 [ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ИНФУЗИОННОГО ВВЕДЕНИЯ ФАВИПИРАВИРА У ПАЦИЕНТОВ, ГОСПИТАЛИЗИРОВАННЫХ С COVID-19]
Balykova L.A., Zaslavskaya K.Ya., Pavelkina V.F., Pyataev N.A., Selezneva N.M., Kirichenko N.V., Ivanova A.Yu., Rodoman G.V., Kolontarev K.B., Skrupsky K.S., Simakina E.N., Mubarakshina O.A., Taganov A.V., Pushkar D.Yu.
Post-exposure prophylaxis of COVID-19: results of double-blind, placebo-controlled, multicenter clinical study evaluation of efficacy and safety of double-stranded sodium salt RNA drug; [Постконтактная профилактика COVID-19: результаты двойного слепого плацебо-контролируемого многоцентрового клинического исследования по оценке эффективности и безопасности применения препарата РНК двуспиральной натриевой соли]
Balykova L.A., Radaeva O.A., Zaslavskaya K.Ya., Taganov A.V., Bely P.A., Zakharov K.A., Popova V.V., Chudinovskikh T.I., Teplykh S.V., Balaban I.V., Kozlov R.S., Kirichenko N.V., Simakina E.N., Koryanova K.N., Pushkar D.Yu.
. At the randomization stage, the subjects were assigned to one of two groups: group 1 (n=400) received a study drug
Evolution and circulation of Yersinia pestis in the Northern Caspian and Northern Aral Sea regions in the 20th-21st centuries
Eroshenko G.A.

Страница 1 из 108165

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core